drugset / Trial / NCT05379491
Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this study is to compare the colon cleansing quality of linaclotide versus control in adult patients at high risk of inadequate bowel preparation: one group will receive polyethylene glycol solution (PEG) split dose (1 L + 2 L) plus linaclotide and the other group PEG (1 L + 2 L) plus placebo before colonoscopy.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-06-30
- Completion
- 2023-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linaclotide | Peptide | — | Oral |
| Comparator | polyethylene glycol | Other / unclassified | 3000 ml | Oral |
Indications
No indication recorded.